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Abstract
Common middle ear diseases may affect bone behavior in the middle
ear air cell system. To understand this pathologic pneumatization, the nor-
mal development of bone in the middle ear should be investigated. The
objective of this study was to analyze gene expression of bone-related sig-
naling factors and gene sets in the developing middle ear. Microarray tech-
nology was used to identify bone-related genes and gene sets, which were
differentially expressed between the lining tissue of adult (quiescent) bulla
and young (resorbing/forming) bulla. Data were analyzed using tools of bio-
informatics and expression levels of selected genes were validated using
quantitative polymerase chain reaction. The candidate gene products were
compared with previously published data on middle ear bone metabolism.
No differentially expressed genes were found on the outer surface of bulla.
On the inner lining a total of 260 genes were identified of which 22 genes
were involved in bone metabolism. Gene set analysis revealed five enriched
bone-related gene sets. The identified differentially expressed bone-related
mRNAs and gene sets are of potential significance in the normally develop-
ing bulla. These factors and gene sets may also play important roles dur-
ing pathologic pneumatization of the middle ear air cell system in common
middle ear diseases. In addition, this study suggests that the control of
growth rate and wall thickness from resorptive as well as formative signals
all originate from the inner lining cells of the bulla wall. Anat Rec,
297:2349–2355, 2014. VC 2014 Wiley Periodicals, Inc.
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Localized bone growth, modeling and remodeling of
the middle ear air cell system (MEACS) result from the
activity of osteoclasts and osteoblasts acting in concert.
In common pathological conditions, such as chronic sup-
purative otitis media and cholesteatoma, this balance is
obviously disturbed. In order to understand pathologic
MEACS remodeling, the mechanisms responsible for
normal physiological control must be determined.
Bone is a hard tissue, consisting of living osteocytes in
a cellular network embedded in a tough, mineralized
intercellular matrix. For this reason any change of bone
size and shape must occur through surface resorption
and surface formation. This involves the combined action
of separate surface populations of osteoclasts and osteo-
blasts acting in concert. The signals required for this
coordination may originate from bone related peptides
expressed in the associated soft lining tissue (functional
matrix). Several studies have investigated the otic cap-
sule (Moss, 1961; Frenz and Van De Water, 1991) and
skull base (Moss et al.,1987; Richards and Jabbour,
2011) morphology from this perspective. In MEACS
development the effects of a dysfunctional tuba, (Hor-
mann, 1986) an altered air pressure, (Wolfman and
Chole, 1986) inflammation (Ikarashi et al., 1994) or
infection (Caye-Thomasen et al., 1999) may result from
bone modeling events triggered by peptide signaling lin-
ing cells.
Previously, sequential fluorochrome-labeling in rab-
bits, has documented how the bone of the bulla wall
grows by bone resorption by osteoclasts on the inner sur-
face of the bulla (IB) and concurrent bone formation by
osteoblasts on the outer surface of the bulla (OB) (Soren-
sen et al., 1992). In a recent study, a baseline growth
plot of rat bullar volume was calculated, showing how
bullar development is taking place in the early stages of
life. The resorption and formation was peaking in young
(10 days old) and completed in adult (80 days old) rats
(Mey et al., 2006) (Fig. 1). Signals that induce resorption
are expected to be higher at the inner bullar surface at
10 days compared to the corresponding signals at 80
days. Consequently, by comparing normalized gene array
results between 10 and 80 days, the gene products
involved in bone resorption may stand out as differen-
tially expressed, while gene product unrelated to resorp-
tion remain unchanged. A similar mechanism may apply
bone formation on the outer surface. With gene arrays it
may be possible to determine the role and importance of
the individual gene and gene set for middle ear bone
signaling.
In this study, gene transcription levels were measured
for bullar bone lining cells in rats on resorbing, forming
and quiescent surfaces using microarrays covering the
entire rat genome. Differentially expressed genes and
enriched gene sets were identified to find gene products
and pathways with a potential for middle ear signaling.
MATERIALS AND METHODS
Animals
Twelve Lewis inbred rats (Charles River) 10 days old
and 12 Lewis inbred rats (Charles River) 80 days old,
were preanaesthetized with inhalation of Halothane 3%.
Surgical anesthesia was induced by Brevimytal Natrium
500 mg (Lilly, Giesen, Germany), 55 mg/kg body weight,
i.p. Following thoracotomy, the heart was opened at the
apex, a self-retaining cannula inserted into the left ven-
tricle and the right atrium was opened. The animals
were vascular perfused and exsanguinated with isotonic
saline. The skull was removed and divided in the mid-
line. Next, the temporal bones were isolated and the
bulla exposed. The outer and inner lining tissues of the
bulla were meticulously isolated and immersed in
RNALaterV
R
(Ambion).
The experiment was conducted in a humane manner
and in accordance with all local, state, and federal
guidelines for the care and utilization of laboratory ani-
mals. It was approved by the Ethical Committee for Ani-
mal Studies (Dyreforsgstilsynet) and the local animal
department and complied with the NIH Guiding Princi-
ples in the Care and Use of animals. All animals had
access to uncontaminated, wholesome, palatable food
and potable, uncontaminated water in sufficient quan-
tity to maintain the normal condition and weight of the
animals. The animals were housed in an environment
with a daily light cycle.
Transcript Profiling
Tissue from each age group was pooled into three
groups of four rats making three biological replicates.
Tissue from the same age group was separated into
outer and inner lining tissue of the bulla. Messenger
RNA was extracted using trizol and six hybridizations
were performed on the microarray platform Affymetrix
GeneChipV
R
Rat Genome 230 2.0. Each tissue type from
each group had a single hybridization and two round
amplifications starting from 100 ng total RNA.
Fig. 1. Growth plot of rat bulla volume versus age and diagrams of
a growing (10 days) and quiescent (80 days) rat bullae. The young
bulla grows with resorption (r) by osteoclasts on the inner surface and
formation (f) by osteoblasts on the outer surface of the bulla. The adult
bulla has quiescent (q) surfaces. Arrows indicate the direction of osse-
ous drift movements.
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Microarray hybridizations, scanning and image prepro-
cessing was done by the Microarray Center of Copenha-
gen University Hospital. The microarray data were
made available in the ArrayExpress database (http://
www.ebi.ac.uk/arrayexpress) under accession number E-
MTAB-2336.
Preprocessing of Microarray Data
All microarray data computations were done with Bio-
conductor 2.8 (Gentleman et al., 2004) using R (R Devel-
opment Core Team, 2011) retrieved from http://www.R-
project.org/. For improved gene expression signal a cus-
tom chip definition file (BrainArray v. 14.0.0) was used
for updated probe-to-RefSeq gene transcript mappings
(Dai et al., 2005). Probe sets were summarized to RefSeq
gene expression values using the GC-RMA algorithm
(Wu et al., 2004) with least-varying-set (LVS) normaliza-
tion (Calza et al., 2008).
Single Gene Differential Analysis
Of all genes, 16% were discarded as nonexpressed on
all arrays using the FLUSH procedure (Calza et al.,
2007) with GC-RMA background subtraction. This
increased the statistical power of testing for differen-
tially expressed genes between young and adult IB and
OB, respectively. The moderated t-test from the Limma
software package was applied to each gene and the
obtained P-values were corrected for multiple testing
using the Benjamini–Hochberg algorithm to control the
False Discovery Rate (FDR) at 5%.
The differentially expressed genes were analyzed
using DAVID web tools (v. 6.7, http://www.david.abcc.
ncifcrf.gov/).
Gene Set Enrichment Analysis
Gene set analysis (Luo et al., 2009) was performed as
planned comparison tests focusing on prespecified gene
sets (public) and novel bone-related gene sets.
Public gene sets were selected from the two databases
MSigDB v. 3.0 and NetPath. MSigDB provided two rele-
vant gene sets: (1) Gene Ontology (Ashburner et al.,
2000) (v. 2008) term “BONE_REMODELING” and (2)
Biocarta (http://www.biocarta.com) RANKL pathway.
NetPath provided RANKL Signaling Pathway (Raju
et al., 2011) as three gene sets.
Novel gene sets were manually curated based on pre-
viously published documentation of genes involved in
bone resorption and bone formation. Genes were anno-
tated “up” or “down” while assigned to five novel gene
sets: (1) Osteoclast related genes, (2) bone dissolving, (3)
osteoclast differentiation, (4) osteoclast migration, adhe-
sion, and polarization, and (5) osteoblast related genes.
Genes comprising sets (1) and (5) were chosen with gen-
eral agreement on the role of these genes. Furthermore,
the public BONE_REMODELING gene set was refined
by dividing it into resorptive and formative genes anno-
tated by up or down. Public gene sets were mapped from
human to rat orthologous gene symbols by InParanoid
database. A P value cutoff of 0.05 was used to indicate
significantly enriched gene sets for each of the two com-
parisons (IB and OB for adult vs. young). Further
details in supplementary.
Validation of the Array Findings
Quantitative polymerase chain reaction (qPCR) was
performed using the High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA)
TABLE 1. Differentially expressed genes related to bone metabolism in inner bulla
Probe set Id Gene name Gene symbol FCa
NM_053822_at S 100 calcium binding protein A8 S100a8 225.0
NM_053663_at Versican Vcan 220.0
NM_031808_at Calpain 6 Capn6 216.7
NM_053587_at S 100 calcium binding protein A9 S100a9 216.7
NM_133514_at Matrix metallopeptidase 10 Mmp10 25.0
NM_001076134_at Collagen, type IV, alpha 2 Col4a2 25.0
NM_001135009_at Collagen, type IV, alpha 1 Col4a1 25.0
NM_012929_at Collagen, type II, alpha 1 Col2a1 25.0
XM_001076840 Collagen, type XI, alpha 1 Col11a1 25.0
NM_031825_at Fibrillin 1 Fbn1 25.0
NM_001107189_at Tenascin N Tnn 25.0
NM_017066_at Pleiotrophin Ptn 23.3
NM_001108318_at ATPase, H1 transporting, lysosomal V1 subunit A Atp6v1a 22.5
NM_012636_at Parathyroid hormone-like hormone Pthlh 22.0
NM_031135_at Kruppel-like factor 10 Klf10 21.7
NM_024141_at Dual oxidase 2 Duox2 15.9
NM_053963_at Matrix metallopeptidase 12 Mmp12 8.3
NM_012938_at Cathepsin E Ctse 3.7
NM_012522_at Cystathionine beta synthase Cbs 2.8
NM_001012089_at Dual specificity protein phosphatase 2 Dusp2 2.7
NM_017325_at Runt related transcription factor 1 Runx1 2.0
NM_138513_at Calcitonin-related polypeptide, beta Calcb 1.8
aFold Change. Negative values represent genes upregulated on the surface in young inner bulla compared with adult inner
bulla samples and positive values represent genes upregulated on the surface in adult inner bulla compared with young
inner bulla.
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according to the manufacturer’s instructions. A 200 ng
total RNA from each of the RNA pools was reverse tran-
scribed. The expression of the transcripts was quantified
using the following assays (Qiagen, Germany): s 100 cal-
cium binding protein A8 (S100a8, QT00402969), calpain
6 (Capn6, QT00180768), s 100 calcium binding protein
A9 (S100a9, QT00175693), matrix metallopeptidase 10
(Mmp10, QT01568028), fibrillin 1 (Fbn1, QT00187215),
tenascin N (Tnn, QT01570478), parathyroid hormone-
like hormone (Pthlh, QT00374766), kruppel-like factor
10 (Klf10, QT01800582), calcitonin-related polypeptide,
beta (Calcb, QT00191709), tumor necrosis factor (ligand)
superfamily, member 11 (RANKL) (Tnfsf11,
QT00195125). The expression was quantitated and nor-
malized to the expression of beta-actin as previously
described (Friis et al., 2011). The validated proteins
were chosen based on fold change (FC) or relevance to
previously published middle ear data.
RESULTS
Bone-Related Single Gene Products
Single gene analysis of the microarray identified 260
significant differentially expressed genes when adult
(quiescent) IB was compared with young (resorbing) IB
(FDR< 0.05). Of these 260 genes, 224 were known and
36 were of unknown function. In all, 22 genes were iden-
tified specific for the bone metabolism on IB (known or
novel). The FC and the individual probe set/gene related
to bone metabolism are shown in Table 1. No significant
differentially expressed genes were found on OB.
Bone-Related Gene Sets
Gene set analysis of all the measured genes against
bone-related gene sets identified five enriched gene sets
(P< 0.05). Three gene sets were enriched on IB, one
gene set was enriched on OB and one gene set was
enriched in both comparisons (Fig. 2).
Validation
The qPCR confirmed the microarray results of the fol-
lowing chosen transcripts; Capn6, Fbn1, Klf10, Mmp10,
Pthlh, S100a8, S100a9, Tnn, and Calcb. The qPCR also
found receptor activator of nuclear factor kappa-B ligand
(RANKL/Tnfsf11) upregulated on the young IB compared
with the adult IB (Fig. 3).
DISCUSSION
The present study is a genome-wide microarray analy-
sis of bone lining cells from the normal developing rat
bulla aiming to identify bone-related candidate genes
and gene sets in the MEACS. FDR was used to assess
significance: If a gene product value is highly variable
even a large FC between, for example, young and adult
IB might represent only chance variation, and not a true
biological difference. However, if stochastic variation is
small, even a slight difference may be significant. By
analyzing statistically the internal variance of triple
measurements the differentially expressed genes could
be identified with a specified risk of error in case of
larger as well as smaller FCs. The single gene analysis
identified 22 differentially expressed genes related to
Fig. 2. Gene set analysis with bone-related gene sets. Five gene
sets were significantly enriched (black numbers) (P< 0.05). Enriched
gene sets from the inner surface of the bulla (IB) and outer surface of
the bulla (OB) from young (10 days old) and adult rats (80 days old)
were compared (IB_adult–IB_young) and (OB_adult–OB_young). The
results revealed both enriched formative and resorptive gene sets on
the IB. The red (blue) colour indicates up (down) gene set regulation in
adult bulla compared with young bulla. Enrichment of gene sets relied
on overall concordance with ‘up’ and ‘down’ gene annotations in the
gene set, as indicated by suffixes ‘u’ or ‘d’, respectively. For gene
sets without gene annotations two aspects of enrichment were ana-
lysed: Coordinate up (or down) regulation of all genes (suffix ‘u’), or
bidirectional regulation (suffix ‘b’) for which both up and down differ-
ential gene expression was counted as concordant with an increased
gene set regulation.
Fig. 3. Validation of the differentially expressed genes. Differentially
expressed bone related genes from the inner bulla. The expression of
ten transcripts identified in the array was validated using quantitative
polymerase chain reaction (qPCR). The qPCR confirmed all the cho-
sen transcripts. The figure shows the fold change in expression of the
adult rat compared to that in the young. All shown changes were sig-
nificant (P< 0.05).
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bone metabolism when adult (quiescent) IB was com-
pared with young (resorbing) IB (FDR< 0.05). Other
genes may be biologically relevant if they work together
as a functional group even if they fail to reach signifi-
cance when analyzed separately: a differential group
effect may become significant only when the correspond-
ing group members are analyzed together as a gene set.
Thus, a gene set analysis on public and novel gene sets
was done. This identified five enriched bone-related gene
sets (P<0.05).
In the following paragraphs some proteins and gene
sets of particular interest are discussed. They were
selected on a fold change or relevance to previously pub-
lished results.
Proteins Previously Highlighted in
Publications on Middle Ear Bone Metabolism
Matrix metalloproteinases (MMPs) are a family of
zinc-dependent endopeptidases. Recently, a study based
on oligonucleotide microarray analyses identified upreg-
ulation of MMP10 in cholesteatoma extracellular matrix
using retroauricular skin as control (Kwon et al., 2006).
MMP10 has also been documented in osteoclasts in
osteophytic bone and neonatal ribs in a study using
immunohistochemistry and in situ zymography (Bord
et al., 1998). This study demonstrated an upregulation
of MMP10 (FC-5.0). The MMP10 seems to play a role as
a regulator of bone resorption in pathological and
healthy MEACS and may potentially have a bone-
signaling function.
Tenascins (TNs) are extracellular matrix glycopro-
teins. There are four members of the TN family: TNC,
TNR, TNX, and TNN. Tenascins have previously been
implicated in middle ear signaling, but the immunohisto-
chemical tools used in the studies did not allow discrimi-
nation between the four members (Lang et al., 1997;
Juhasz et al., 2009). In the present study, the TNN was
upregulated in young IB (FC 25.0) and may have a pos-
sible bone-signaling role in the middle ear.
Novel Bone-Related Proteins of the Middle Ear
Calcium-binding protein molecule A8 (S100A8) and
calcium-binding protein molecule A9 (S100A9) are
involved in the regulation of a number of cellular proc-
esses. They are localized in the cytoplasm and/or nucleus
of a wide range of cells including osteoblasts and osteo-
clasts (Zreiqat et al., 2007). Recently, S100A8 was shown
to stimulate osteoclast differentiation and activity dur-
ing space flight (Sambandam et al., 2010). In this study
S100A8 (FC 225.0) and S100A9 (FC 216.7) were upreg-
ulated in young IB implicating a potential effect on the
osteoblasts and osteoclasts in the normal growing
MEACS.
Calpains (CAPNs) form a group of 14 members of
calcium-sensitive cysteine proteases. In a biochemical
study CAPN I and II were suggested to participate in
the middle ear bone resorption associated with choles-
teatoma by their involvement in collagen destruction
(Amar et al., 1996). In addition, CAPN6 has been identi-
fied as a regulator of osteoclastic bone resorption via
cytoskeletal organization and microtubule acetylation
(Hong et al., 2011). In the present study a significant
upregulation of CAPN6 (216.7) in young IB was
demonstrated.
Fibrillin-1 (FBN1) is an extracellular matrix glycopro-
tein that is altered in Marfan syndrome, characterized
by, for example, defects in the skeletal system. Recently,
FBN1 and FBN2 were found to be implicated in bone
formation through a process involving the regulation of
local TGFb and bone morphogenetic protein signals (Nis-
tala et al., 2010). In accordance with these results, this
study showed an upregulation of FBN1 on young IB (FC
25.0). Therefore, FBN1 may be a medium range signal-
ing protein for coupled bone formation on OB.
Calcitonin-related polypeptide (CALC) is a neuropep-
tide which exists in two forms, CALCA and CALCB. The
MEACS might be under control of the nervous system
as denervation resulted in bone resorption inside the
bulla of the Mongolian gerbil (Sherman and Chole, 1996;
Sherman and Chole, 1999; Sherman and Chole, 2001).
This was assumed to result from the blocking of cate-
cholamines but also due to inhibition of neuropeptides
such as substance P and nerve growth factor (Sherman
and Chole, 1995). In the present study, CALCB was sig-
nificant differentially upregulated in adult IB (FC 1.8)
in accordance with the suggested role of this neuropep-
tide as an inhibitor of osteoclast resorption (Yamamoto
et al., 1986).
The bulla of the rat is a hollow bony structure. During
development the growing bulla maintains a constant 60
mm wall thickness. Consequently a dynamic equilibrium
exists between the resorbing osteoclasts acting on IB
and the forming osteoblasts acting on OB. The signals
that link and adjust resorption and formation on oppos-
ing bony surfaces are unknown. Forming and resorbing
signals might be generated on OB and IB, respectively.
Alternatively, all rate controlling signals might originate
only on one side, either the outside or the inside to coor-
dinate cellular activities on both sides simultaneously
through short- and medium range signaling. In this
study no differentially expressed single genes were iden-
tified on the OB. This finding favors a location of the
basic rate controlling growth signal at the IB. Theoreti-
cally, a short range resorptive signal might control bone
resorption on the inner bullar surface, while a coupled
medium range formative signal might reach the outer
surface through the bullar wall via the lacuno-
canalicular porosity or the cellular osteocytic network at
a 60 mm distance (Drossopoulou et al., 2000). This may
explain how a constant wall thickness is maintained
even when the rate of resorption varies.
The present study demonstrated differential expression
of osteoblast related proteins like S100A8, S100A9, and
FBN. It also showed osteoclast related proteins like;
MMP10, TNN, S100A8, S100A9, CAPN6, and CALCB on
the IB surface. Some of the factors have previously been
reported in the middle ear literature (Amar et al., 1996;
Lang et al., 1997; Kwon et al., 2006; Juhasz et al., 2009)
while others are new candidate genes in MEACS model-
ing. Furthermore, the novel gene sets “osteoclast related
genes”, “osteoblast related genes” and the formative genes
comprising the public gene set “BONE_REMODELING”
were also significantly enriched on the IB. This indicates
that the controlling signals originate on the inside and
that the genes work in functional groups.
Differentially expressed signals may be overlooked for
a number of reasons. Individual osteoclasts are very
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effective and the process of resorption may proceed at a
high rate with only a few active osteoclasts involved.
Besides, important bone-related genes may be lost
through attenuation by dilution as they may be found
only in the smaller fraction of the lining tissue, which
represents the osteoclast domain in close contact with
the bone surface. Future isolation of such microscopic
subpopulations of lining cells may be possible with the
laser microdissection technique (Markaryan et al., 2011).
Furthermore, signaling proteins may be secreted in a
cyclical pattern rather than continually and some signal-
ing proteins may reach the lining cells via an opposite
route from within the lacuna–canalicular system.
Finally, in this study the levels of mRNA expression
determined were assumed to correspond to the levels of
protein abundance (transcriptional control). In the path-
way from DNA to RNA to protein the gene expression
can be regulated at many steps. Some studies show
results with limited correlations between mRNA and
protein expression levels (Greenbaum et al., 2003). This
may result from another level of regulation of gene
expression or because of stochastic noise in mRNA and
protein expression experiments. However, for most genes
transcriptional controls are thought to be paramount as
only this kind of control ensures that no superfluous
intermediates are synthesized.
The qPCR validation confirmed all the microarray
results except for RANKL. The qPCR result of RANKL
was contrary to the array data significant. Thus, inde-
pendent validation of microarray data continues to be an
important consideration.
The present study of lining tissue in the normal devel-
oping bulla identified several differentially expressed
genes and gene sets of potential significance. These fac-
tors and gene sets may also play important roles during
pathologic pneumatization of the middle ear air cell sys-
tem in common middle ear diseases. Furthermore,
resorptive as well as formative signals may all originate
from IB lining cells. Future array studies on young ani-
mals with experimental otitis compared to the present
results may offer important clinical information by dem-
onstrating which of the differentially expressed gene
products are responsible for the decreased pneumatiza-
tion caused by otitis media. Furthermore, future studies
should include other methodologies, for example, miRNA
and proteomics analyses. This may reveal more informa-
tion about the bone metabolism in the MEACS and ver-
ify the observed changes of gene expression in this
study.
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